AI has gained recognition from pharmaceutical giants! Novo-Nordisk A/S: AI is finally reliable enough to generate sensitive documents. (FUTU)

Novo Nordisk has successfully integrated Anthropic’s Claude 3.5 Sonnet AI into drafting regulatory drug documents, significantly reducing errors and slashing the process from 15 weeks to under 10 minutes. Previously requiring over 50 writers, the task is now handled by just three, thanks to AI-assisted workflows. The company employs retrieval-augmented generation (RAG) to enhance accuracy, ensuring AI-generated content aligns with expert-approved definitions. Despite cost savings—less than a single writer’s salary—Novo Nordisk says it won’t cut staff but will slow hiring. This shift marks an unprecedented acceleration in AI adoption within the highly regulated pharmaceutical industry.